T 0534/07 (CD8 T cells/OXXON THERAPEUTICS) of 25.11.2008

European Case Law Identifier: ECLI:EP:BA:2008:T053407.20081125
Date of decision: 25 November 2008
Case number: T 0534/07
Application number: 98928434.4
IPC class: C12N 15/30
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 101 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Reagents for vaccination which generate a CD8 T cell immune response
Applicant name: Oxxon Therapeutics Limited
Opponent name: Sanofi Pasteur
OXFORD BIOMEDICA (UK) LTD.
Therion Biologics Corporation
POWDERJECT VACCINES INC.
Danisco US Inc
Board: 3.3.08
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 134(5)
European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 83
European Patent Convention 1973 Art 108
European Patent Convention 1973 Art 54(3)
European Patent Convention 1973 R 65(1)
Keywords: Admissibility of appellant II's appeal - (no) - missing statement of grounds
Admissibility of appellant I's appeal - (yes)
Exclusion of representatives - (no) - no legal basis
Novelty - (yes)
Inventive step - (yes)
Sufficiency of disclosure (yes)
Catchwords:

-

Cited decisions:
J 0010/07
T 0606/89
T 0254/93
T 1009/97
T 0836/01
T 0315/03
T 0509/04
Citing decisions:
-

7 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: III Amendments

General Case Law